CTLs: Stormtroopers of the Immune System

amfAR-funded researcher Dr. Brad Jones talks about the latest approaches being used to harness a subset of immune cells in the search for a cure.

• Breaking a Vicious Circle - Controlling HIV Reservoirs by Targeting Inflammation
• Attacking HIV in the Gut

amfAR Calls for Increase in HIV/AIDS Research Funding at National Institutes of Health

A new infographic details declining purchasing power of NIH’s HIV/AIDS research dollars.

• A Step Forward for HIV Prevention
• Congress Eases Restrictions on Funding for Syringe Exchange

amfAR’s Dr. Annette Sohn Featured in South China Morning Post

Dr. Sohn, director of amfAR’s TREAT Asia program, discusses the alarming global increase in adolescent HIV-related deaths.

• Addressing the Challenges to HIV/Hepatitis C Treatment Access
• A Mission to Mobilize HIV Communities Worldwide

A New Take on an Old Vaccine Idea

HIV vaccine studies have taken many twists and turns over the years and vaccines are increasingly seen as playing an important role in a potential HIV cure. Dr. Steve Deeks of UCSF and the amfAR Institute for HIV Cure Research explains.

An Exciting New Research Collaboration

The California-based Institute supports teams of scientists working across the research continuum, from basic science to clinical studies.

Video: amfAR’s Search for a Cure

This short new video showcases amfAR's single-minded pursuit of a cure for HIV and describes the scientific hurdles that stand in the way.

Countdown to a Cure Timepiece

amfAR's Milestone Partner, Harry Winston, Inc., is launching a limited-edition Countdown to a Cure timepiece to benefit the Foundation's efforts to develop a cure for HIV.